OTRIVIN

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Finland, Hong Kong SAR China, Israel, Lithuania, Malta, Netherlands, New Zealand, Nigeria, Poland, Singapore, South Africa.

Active ingredients

The drug OTRIVIN contains one active pharmaceutical ingredient (API):

1	Xylometazoline UNII X5S84033NZ - XYLOMETAZOLINE HYDROCHLORIDE
	Xylometazoline acts directly on α-adrenoreceptors but does not act on β-receptors. When used topically as a nasal decongestant, xylometazoline acts rapidly and provides long-lasting relief. Onset of action is within minutes, the decongestant effect being prolonged and lasting for up to 10 hours.
	Read more about Xylometazoline

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OTRIVIN ADULT Menthol Nasal spray, solution	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R01AA07	Xylometazoline	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AA Sympathomimetics, plain
Discover more medicines within R01AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00653330, 02208903, 02331403
EE	Ravimiamet	1007020, 1007053, 1035975, 1035997
FI	Lääkealan turvallisuus- ja kehittämiskeskus	018176, 180539, 433136, 439794
HK	Department of Health Drug Office	00187, 00195, 00219, 60243, 60495
IL	מִשְׂרַד הַבְּרִיאוּת	3995, 573, 574, 575, 576, 577, 578
LT	Valstybinė vaistų kontrolės tarnyba	1007955, 1007956, 1015136, 1015614
MT	Medicines Authority	MA1177/00301, MA1177/00302, MA1177/00303, MA1177/00304, PI908/04005A
NG	Registered Drug Product Database	04-0026, 04-5350
NL	Z-Index G-Standaard	14708272, 14708280, 14708337
NL	Z-Index G-Standaard, PRK	43311, 6661, 6688
NZ	Medicines and Medical Devices Safety Authority	11729, 11730, 11731, 11732, 7834
PL	Rejestru Produktów Leczniczych	100108728, 100108740, 100108757, 100307132, 100379893, 100380152, 100386717, 100397253, 100407610, 100408028, 100413638, 100438868
SG	Health Sciences Authority	11622P, 11623P, 11624P
ZA	Health Products Regulatory Authority	31/16.1/0319, H/16.1/1381, H/16.1/1382, J/16.1/311